Glaxosmithkline Pharmaceuticals consolidated net profit rises 28.60% in the December 2025 quarter
Sales rise 9.67% to Rs 1041.26 crore
Net profit of Glaxosmithkline Pharmaceuticals rose 28.60% to Rs 295.62 crore in the quarter ended December 2025 as against Rs 229.88 crore during the previous quarter ended December 2024. Sales rose 9.67% to Rs 1041.26 crore in the quarter ended December 2025 as against Rs 949.42 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales1041.26949.42 10 OPM %35.6630.75 -PBDT402.27326.90 23 PBT381.95308.10 24 NP295.62229.88 29Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 09 2026 | 5:54 PM IST